Research Reports

East India Pharmaceutical Works Limited Unlisted Shares

East India Pharmaceutical Works Limited company logo

East India Pharmaceutical Works Limited Share Price

PHYSICAL

PUBLIC LIMITED

Price Chart

1W
1M
1Y
MAX

High

₹100

Low

₹100

Return

-

East India Pharmaceutical Works Limited Essentials

As of April 30, 2026, East India Pharmaceutical Works, Unlisted Shares are trading at ₹100.00 per share and face value is ₹10.00/share, with a 52-week high of ₹100.00 and 52-week low of ₹100.00. The minimun lot size is 2600 shares, and the shares are traded on NSDL and CDSL.

ISIN

info icon

INE254X01017

Face Value

info icon

10

Total Shares

info icon

66,74,858

Market Cap

info icon

66.75 Cr

Profit After Tax

info icon

1.69 Cr

Total Revenue

info icon

233.35 Cr

P/E

info icon

39.53

P/B

info icon

1.28

Sector

info icon

Health Care

Sub-sector

info icon

Pharmaceuticals

Category

info icon

Micro Cap

Cashflow - Operations

info icon

-3.11 Cr

About East India Pharmaceutical Works Limited

Company Overview:

  • East India Pharmaceutical Work Limited is involved in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including generic drugs, branded formulations, and over-the-counter (OTC) medicines, with expertise in various therapeutic areas, including anti-infectives, analgesics, anti-diabetics, respiratory, cardiovascular, gastrointestinal, vitamins and minerals, dermaceuticals, and nutritional supplements.
  • With 85 years of excellence, East India Pharmaceutical Works has dedicated its efforts towards envisaging and defining scientific solutions, thereby ushering in a range of revolutionary quality pharmaceutical products catering to growth and needs in the healthcare industry.
  • The company is focusing on expanding its international presence and exploring new market opportunities. The company is exporting medicines to over 50 countries worldwide, covering regions like Asia, Africa, Europe, Latin America, and North America.
  • East India Pharmaceutical Works developed several first-of-its-kind generic drugs in India, including the first indigenously developed antimalarial drug, the first generic version of metformin (anti-diabetic), and the first generic version of ramipril (anti-hypertensive). The company also has a strong pipeline of new products in development across various therapeutic areas.
  • With the help of consumer understanding and continuous development through advanced research, the company offers over 100 medical products under bands like Enteroquinol, Vitazyme, Locula, Bactiv, Tonoferon, and Pyrigesic to cater to a wide range of healthcare needs.
  • East India Pharmaceutical Works Limited is a Public incorporated on 27 April 1936, with its registered office at 6, Nandalal Bose Sarani Kolkata WB 700071 IN.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

East India Pharmaceutical Works Limited Media

News

Articles

Videos

No News available for this company.

East India Pharmaceutical Works Limited

₹ 100

cartIcon